Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 75.0 | 34.5 | 7.7 | 6.2 |
| Revenue growth | 117.6% | 346.7% | 25.1% | |
| Cost of goods sold | 37.9 | 18.6 | 9.0 | 8.1 |
| Gross profit | 37.1 | 15.9 | -1.3 | -1.9 |
| Gross margin | 49.4% | 46.0% | -16.3% | -30.6% |
| Selling, general and administrative | 88.8 | 51.0 | 30.3 | 28.5 |
| Research and development | 29.0 | 19.0 | 16.3 | 13.1 |
| EBITA | -80.4 | -53.9 | -47.8 | -43.6 |
| EBITA margin | -107.2% | -156.2% | -619.4% | -705.9% |
| Amortization of intangibles | 0.3 | 0.3 | | |
| EBIT | -80.7 | -54.2 | -47.8 | -43.6 |
| EBIT margin | -107.6% | -157.1% | -619.4% | -705.9% |
| Pre-tax income | -87.2 | -59.9 | -53.0 | -42.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -87.2 | -59.9 | -53.0 | -42.0 |
| Net margin | -116.2% | -173.6% | -687.0% | -680.4% |
| |
| Diluted EPS | ($1.96) | ($3.63) | ($14.47) | ($19.01) |
| Shares outstanding (diluted) | 44.4 | 16.5 | 3.7 | 2.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|